drugset / Trial / NCT00907985

A Study to Evaluate the Effect of Single Doses of Drug A (Lamotrigine) and Drug B (Vofopitant) Alone and in Combination on Resting Motor Threshold in Healthy Subjects

NCT00907985

Phase 1 Terminated 12 enrolled GlaxoSmithKline
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to investigate the effect of drug A on its own and when it is given in combination with drug B on markers of brain activity. The study will 1. Assess the effects of drug A and drug B on muscle movement after brain stimulation; 2. Examine how the body handles (absorbs, distributes, breaks down and gets rid of) drug A and drug B when given in combination; 3. Examine the safety of drug A and drug B when given together.

Timeline

Start
2009-05-15
Primary completion
2010-06-10
Completion
2010-06-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Lamotrigine Small molecule 25 mg Oral
Subject Lamotrigine Small molecule 100 mg Oral
Subject Lamotrigine Small molecule 150 mg Oral
Subject Lamotrigine Small molecule 175 mg Oral
Subject Vofopitant Small molecule 5 mg Oral
Subject Vofopitant Small molecule 10 mg Oral

Indications